Hydrophilic verapamil∙HCl, a calcium channel-blocking agent, is an inhibitor of P-gp and increases the accumulation of anticancer drugs in cancer cells by preventing anticancer drugs from escaping to the outside of the cell through the P-gp [97]. The gene discussed is PGP; the disease is cancer.